149 related articles for article (PubMed ID: 14666386)
21. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
22. [Usefulness of quantification and visual analysis of the uptake of (99m)Tc-MIBI in the diagnosis of mammary lesions].
Mulero F; Roca V; Nicolás F; Castellón I; Fuentes T; Abad L; Illana J; Nuño de la Rosa JA
Rev Esp Med Nucl; 2000 Jun; 19(3):192-8. PubMed ID: 11062082
[TBL] [Abstract][Full Text] [Related]
23. Expression of drug resistance protein related to Tc-99m MIBI breast imaging.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(3B):2021-5. PubMed ID: 10928145
[TBL] [Abstract][Full Text] [Related]
24. Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines.
de Jong M; Bernard BF; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; Krenning EP
Eur J Nucl Med; 1996 Oct; 23(10):1361-6. PubMed ID: 8781141
[TBL] [Abstract][Full Text] [Related]
25. [Usefulness of the quantification of (99M)Tc-MIBI uptake in breast neoplasms in the preoperative assessment of tumor aggressiveness].
Mulero F; Nicolás F; Roca V; Castellón MA; Claver MA; de La Cruz P; Abad L; Nuño De La Rosa JA
Rev Esp Med Nucl; 2000 Aug; 19(4):263-9. PubMed ID: 11062096
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the uptake and clearance of Tc-99m MIBI, Tl-201 and Ga-67 in drug-resistant lymphoma cell lines.
Tsai SC; Shiau YC; Wang JJ; Ho YJ; Kao CH
Cancer Lett; 2001 Oct; 171(2):147-52. PubMed ID: 11520598
[TBL] [Abstract][Full Text] [Related]
27. Monitoring mitochondrial metabolisms in irradiated human cancer cells with (99m)Tc-MIBI.
Furuta M; Nozaki M; Kawashima M; Iimuro M; Okayama A; Fukushima M; Natsui S; Souma R; Jinnai M
Cancer Lett; 2004 Aug; 212(1):105-11. PubMed ID: 15246566
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Effect of Resveratrol and Doxorubicin on
Hallajian F; Ghasmi M; Abedi SM; Behzadi R; Hayati E; Sadeghzadeh N; Rezazadeh F; Karimi H
Cancer Biother Radiopharm; 2018 Nov; 33(9):403-410. PubMed ID: 30040447
[TBL] [Abstract][Full Text] [Related]
29. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
30. [The relationship between 99mTc-MIBI scintimammography of breast cancer and multidrug-resistant proteins].
Cui SD; Liu ZZ; Liu H; Li LF; Yang H; Li WL
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):606-8. PubMed ID: 16438870
[TBL] [Abstract][Full Text] [Related]
31. Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging.
Yoon HJ; Kim Y; Lee JE; Kim BS
Eur Radiol; 2015 Jan; 25(1):32-40. PubMed ID: 25216768
[TBL] [Abstract][Full Text] [Related]
32. Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models.
Ohira H; Kubota K; Ohuchi N; Harada Y; Fukuda H; Satomi S
J Nucl Med; 2000 Sep; 41(9):1561-8. PubMed ID: 10994739
[TBL] [Abstract][Full Text] [Related]
33. [Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.
Mankoff DA; Dunnwald LK; Gralow JR; Ellis GK; Schubert EK; Charlop AW; Tseng J; Rinn KJ; Livingston RB
Nucl Med Biol; 2002 Oct; 29(7):719-27. PubMed ID: 12381452
[TBL] [Abstract][Full Text] [Related]
34. Uptake of Tc-99m MIBI related to tumour size and type.
Buscombe JR; Cwikla JB; Thakrar DS; Hilson AJ
Anticancer Res; 1997; 17(3B):1693-4. PubMed ID: 9179220
[TBL] [Abstract][Full Text] [Related]
35. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
Zhang XM; Zhang ZW; Wu H
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
[TBL] [Abstract][Full Text] [Related]
36. To use MIBI or not to use MIBI? That is the question when assessing tumour cells.
Moretti JL; Hauet N; Caglar M; Rebillard O; Burak Z
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):836-42. PubMed ID: 15902437
[TBL] [Abstract][Full Text] [Related]
37. Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions.
Omar WS; Eissa S; Moustafa H; Farag H; Ezzat I; Abdel-Dayem HM
Anticancer Res; 1997; 17(3B):1639-44. PubMed ID: 9179210
[TBL] [Abstract][Full Text] [Related]
38. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
39. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice.
Liu Z; Stevenson GD; Barrett HH; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Woolfenden JM; Pak KY
Nucl Med Commun; 2004 Jul; 25(7):711-20. PubMed ID: 15208499
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.
Kabasakal L; Ozker K; Hayward M; Akansel G; Griffith O; Isitman AT; Hellman R; Collier D
Eur J Nucl Med; 1996 May; 23(5):568-70. PubMed ID: 8698063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
